Michael Stratton

Michael Stratton at the Wellcome Sanger Institute co-discovered BRCA2 and has led landmark cancer genome sequencing projects. His development of the concept of mutational signatures — characteristic patterns of somatic mutations reflecting specific DNA damage mechanisms and repair deficiencies — has been highly influential for understanding cancer biology. The COSMIC mutational signatures catalog, developed under his leadership, is a foundational resource for cancer genomics.